Manufacturer Supply Nucleosides Intermediates with High Purity and Stable Quality
| Cytidine CAS: 65-46-3 | Uridine CAS: 58-96-8 |
| Adenosine CAS: 58-61-7 | Guanosine CAS: 118-00-3 |
| 5-Azacytidine CAS: 320-67-2 | 2-Chloroadenosine CAS: 146-77-0 |
| 2-Aminoadenosine CAS: 2096-10-8 | Capecitabine CAS: 154361-50-9 |
| Name | 5-Azacytidine |
| CAS Number | 320-67-2 |
| CAT Number | RF-PI194 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C8H12N4O5 |
| Molecular Weight | 244.21 |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Appearance | White or Almost White Crystalline Powder |
| Purity / Analysis Method | ≥98.5% (HPLC) |
| Loss on Drying | ≤1.0% |
| Residue on Ignition | ≤0.50% |
| Heavy Metals (as Pb) | ≤20ppm |
| Test Standard | Enterprise Standard |
| Usage | Pharmaceutical Intermediates; Organic Synthesis |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 5-Azacytidine (CAS: 320-67-2) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and API.
Manufacturer Supply Nucleosides Intermediates with High Purity and Stable Quality
| Cytidine CAS: 65-46-3 | Uridine CAS: 58-96-8 |
| Adenosine CAS: 58-61-7 | Guanosine CAS: 118-00-3 |
| 5-Azacytidine CAS: 320-67-2 | 2-Chloroadenosine CAS: 146-77-0 |
| 2-Aminoadenosine CAS: 2096-10-8 | Capecitabine CAS: 154361-50-9 |
Azacytidine also referred to as Azacytidine and 5-azacytidine (brand name: Vidaza) is an anti-cancer chemotherapy medication. The drug is classified as demethylation and antimetabolite agent. Azacytidine acts by inhibiting the growth and proliferation of cancer cells in the body. The drug is indicated for the treatment of specific types of blood cell disorders and bone marrow cancers. Azacytidine is prescribed for treating patients with secondary types of myelodysplastic syndrome, including refractory anemia that presents in the form of ringed sideroblasts (especially if it necessitates transfusion), or it presents itself alongside thrombocytopenia or neutropenia. Also, it is used in treating refractory anemia accompanied by excess blasts, refractory anemia characterized by excess blasts in transition (currently classified as chronic myelogenous leukemia that is accompanied by multilineage dysplasia), and acute myelomonocytic leukemia. 5-Azacytidine is a chemical analog that is closely linked with the cytosine nucleoside in ribonucleic acid (RNA) and deoxyribonucleic acid (DNA).